Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Narod

Showing results (251-260 of 544) with videos related to

Pageof 55
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2011
Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancerCezary Cybulski, Dominika Wokołorczyk, Anna Jakubowska, et al.
Breast Cancer Research and Treatment|January 25, 2005
The 3020insC allele of NOD2 predisposes to early-onset breast cancerTomasz Huzarski, Marcin Lener, Wenancjusz Domagała, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
CHEK2-positive breast cancers in young Polish womenCezary Cybulski, Bohdan Górski, Tomasz Huzarski, et al.
Journal of the National Cancer Institute|December 22, 2012
Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2John R McLaughlin, Barry Rosen, Joel Moody, et al.
BMJ (Clinical Research Ed.)|March 4, 2016
Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysisChristopher J D Wallis, Alyson L Mahar, Richard Choo, et al.
BJU International|December 22, 2004
Variation in patterns of practice in diagnosing screen-detected prostate cancerRobert K Nam, Ants Toi, John Trachtenberg, et al.
Cancer|August 20, 2015
A high frequency of BRCA mutations in young black women with breast cancer residing in FloridaTuya Pal, Devon Bonner, Deborah Cragun, et al.
Fertility and Sterility|December 25, 2015
Treatment of infertility does not increase the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutationJacek Gronwald, Karen Glass, Barry Rosen, et al.
The Journal of Urology|January 13, 2006
Making sense of prostate specific antigen: improving its predictive value in patients undergoing prostate biopsyRobert K Nam, Ants Toi, John Trachtenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
The use of genetic markers to determine risk for prostate cancer at prostate biopsyRobert K Nam, William W Zhang, Michael A S Jewett, et al.
Pageof 55

Showing results (251-260 of 544) with videos related to

Sort By:
Pageof 55
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2011
Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancerCezary Cybulski, Dominika Wokołorczyk, Anna Jakubowska, et al.
Breast Cancer Research and Treatment|January 25, 2005
The 3020insC allele of NOD2 predisposes to early-onset breast cancerTomasz Huzarski, Marcin Lener, Wenancjusz Domagała, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
CHEK2-positive breast cancers in young Polish womenCezary Cybulski, Bohdan Górski, Tomasz Huzarski, et al.
Journal of the National Cancer Institute|December 22, 2012
Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2John R McLaughlin, Barry Rosen, Joel Moody, et al.
BMJ (Clinical Research Ed.)|March 4, 2016
Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysisChristopher J D Wallis, Alyson L Mahar, Richard Choo, et al.
BJU International|December 22, 2004
Variation in patterns of practice in diagnosing screen-detected prostate cancerRobert K Nam, Ants Toi, John Trachtenberg, et al.
Cancer|August 20, 2015
A high frequency of BRCA mutations in young black women with breast cancer residing in FloridaTuya Pal, Devon Bonner, Deborah Cragun, et al.
Fertility and Sterility|December 25, 2015
Treatment of infertility does not increase the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutationJacek Gronwald, Karen Glass, Barry Rosen, et al.
The Journal of Urology|January 13, 2006
Making sense of prostate specific antigen: improving its predictive value in patients undergoing prostate biopsyRobert K Nam, Ants Toi, John Trachtenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
The use of genetic markers to determine risk for prostate cancer at prostate biopsyRobert K Nam, William W Zhang, Michael A S Jewett, et al.
Pageof 55